MS treatment satisfaction under the microscope: global study launches

NCT ID NCT07504783

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to understand how satisfied both doctors and patients are with current multiple sclerosis (MS) treatments in everyday medical practice. Researchers will collect information from 261 patients and their physicians across several countries, including the UK, France, Germany, Italy, Spain, China, Japan, and Brazil. The goal is to identify factors that influence satisfaction and how patients feel their current medication compares to previous ones.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multiple sclerosis Patient Satisfaction Personal Satisfaction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Novartis

    Basel, CH-4056, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.